Sodium sesquihydrate—more precisely known as sodium sesquicarbonate sesquihydrate—is a buffering agent and mild alkaline compound composed of a mixture of sodium carbonate (Na₂CO₃) and sodium bicarbonate (NaHCO₃). It has been utilized in various industries, including pharmaceuticals, as a pH regulator, urinary alkalinizer, and mucolytic agent, among other roles. While it is not considered a classical active pharmaceutical ingredient (API) in the sense of possessing direct therapeutic pharmacodynamics, its physicochemical properties make it useful in both systemic and topical formulations, particularly in urology, ophthalmology, and dermatology.
Chemical Structure
Chemically, sodium sesquihydrate is a double salt of sodium bicarbonate and sodium carbonate, often represented as:
Na₃H(CO₃)₂ · 1.5 H₂O
It exists as a white crystalline powder and is highly soluble in water, releasing alkaline ions that neutralize acidity in biological fluids. Its sesquihydrate form means that 1.5 molecules of water are associated per formula unit, contributing to its hydration-dependent crystalline behavior.
This compound serves as a mild base, forming alkaline solutions when dissolved, which makes it effective in modifying the pH of physiological fluids or formulations.
Sodium Sesquihydrate-Based Medicines List
- Ural Effervescent Granules – Used as a urinary alkalinizer for cystitis relief.
- Alka-Ur – Common in urinary tract infection symptom relief as a pH buffer.
- Citralka (with sodium salts) – Combination agent for urinary acidity management.
- Sodibicarb-Sesqui Drops – Ophthalmic solution to correct ocular pH in specific conditions.
- Mucosolvan pH-Adjusted Inhalation – Nebulizer solutions may include buffering agents like sodium sesquihydrate.
- Dermasol Bath Additive – Used in dermatologic conditions for pH balancing in eczema or dermatitis.
- Uro-Balance Sachets – Bladder pH adjustment and cystitis symptom control.
- Custom Compounded Sodium Buffer Solutions – For urology or nephrology applications (clinical use only).
Mechanism of Action
Sodium sesquihydrate acts as a physiological pH buffer. When administered orally or topically, it modulates acidity by neutralizing excess hydrogen ions. This leads to increased pH in the targeted area, whether it’s the urine, ocular surface, or skin.
In urinary alkalinization, the increase in urinary pH can relieve burning micturition, enhance solubility of certain medications, and reduce crystallization of uric acid or cystine, thereby preventing stone formation. In topical and ophthalmic uses, it helps maintain pH homeostasis, particularly where acidic inflammation contributes to symptoms.
Pharmacokinetics
“Sodium sesquihydrate” is not metabolized in the body like traditional drugs. Its activity is entirely chemical and ionic. The pharmacokinetic considerations include:
- Absorption: Not systemically absorbed in its intact form. Components such as sodium and carbonate ions may be absorbed and regulated via normal physiological pathways.
- Distribution: Minimal systemic distribution; acts locally in the urinary tract or at application sites.
- Metabolism: No enzymatic metabolism occurs.
- Excretion: Excess sodium and bicarbonate are eliminated via the kidneys in urine.
- Onset of Action: Rapid onset for pH modification within 30–60 minutes after oral intake.
- Duration of Effect: pH-modifying effect may last for 4–6 hours, depending on urinary flow and intake volume.
Therapeutic Uses
| Indication | Role of Sodium Sesquihydrate |
|---|---|
| Urinary tract infections (UTIs) | Alkalinizes urine to reduce discomfort and acidity |
| Uric acid stone prevention | Prevents crystallization by increasing urinary pH |
| Cystitis (non-infective and infective) | Symptomatic relief of burning and urgency |
| Ophthalmic acid burns or acidosis | Neutralizes acidic ocular pH in chemical exposure |
| Atopic dermatitis/eczema | Balances skin pH to restore barrier function |
| Mucolytic support in respiratory care | Used in nebulizers to adjust mucus viscosity via pH |
| Drug excretion modulation | Enhances renal elimination of weak acids (e.g., salicylates) |
| Supportive therapy in acidosis | Provides mild alkalinizing effects in metabolic acidosis |
Side Effects
Sodium sesquihydrate is generally well-tolerated, particularly when used in controlled doses. However, adverse effects may occur, especially with chronic or excessive intake:
- Gastrointestinal: Bloating, flatulence, nausea due to CO₂ production.
- Metabolic: Metabolic alkalosis in overdose or prolonged use.
- Electrolyte imbalance: High sodium levels may cause hypernatremia in sensitive individuals.
- Renal: In patients with renal impairment, sodium load may exacerbate fluid retention or electrolyte imbalance.
- Topical irritation: May occasionally cause dryness or irritation when applied to damaged skin.
Drug Interactions
As a pH modifier and sodium-containing agent, sodium sesquihydrate may interact with:
- Weakly acidic drugs (e.g., aspirin, methotrexate): Altered urinary excretion due to pH changes.
- Antacids: Additive alkalinization effects may increase systemic pH excessively.
- Potassium-sparing diuretics: Risk of electrolyte imbalance.
- Lithium: Sodium intake can alter lithium clearance.
- Enteric-coated medications: Alkalinization may cause premature dissolution in the stomach.
Careful attention to timing of administration is essential to avoid compromising drug absorption or elimination kinetics.
Safety Considerations
Sodium sesquihydrate is considered safe for short-term and targeted use, but several safety aspects must be considered:
- Renal Disease: Use cautiously due to sodium load and risk of electrolyte disturbances.
- Heart Failure or Hypertension: High sodium intake may worsen fluid retention and blood pressure.
- Pregnancy and Lactation: Generally regarded as safe in small doses; however, excessive sodium may cause water retention.
- Pediatrics: Safe in adjusted doses for urinary alkalinization; overuse can cause imbalances.
- Elderly: Increased sensitivity to sodium; monitor electrolytes with long-term use.
Hydration is important when sodium sesquihydrate is used orally to avoid crystalluria or renal irritation.
Regulatory Status
Sodium sesquihydrate is not classified as a controlled substance and is commonly found in over-the-counter urinary alkalinizers and topical agents. It is recognized by pharmacopoeias for use in compounded prescriptions and over-the-counter formulations. Regulatory agencies such as the U.S. FDA, EMA, TGA, and others have allowed its use primarily as an excipients-class buffer or supportive active, depending on the formulation and therapeutic goal.
In most markets, sodium sesquihydrate is regulated as a safe additive or excipient but can function as an API in products where pH control is the central therapeutic mechanism.
